fbpx

Best Biotech Stocks Right Now

Looking for biotech stocks to diversify your portfolio? These companies may be worth investing in.

Benzinga Money is a reader-supported publication. We may earn a commission when you click on links in this article. Learn more.

BioSpecifics Technologies (NASDAQ: BSTC)

BioSpecifics Technologies Corp. is a biopharmaceutical company that originated collagenase-based therapies. Collagenases are naturally occurring enzymes responsible for the breakdown of collagen, the most abundant protein in mammals. Its primary product is XIAFLEX® and is used for the treatment of Dupuytren’s disease and Peyronie’s disease.

The biotech stock has a market cap of $453 million and has an EPS of $2.48. It has an average monthly trade volume of 33,153 shares. BioSpecifics generated revenue of $38 million in 2019.

88.10 -0.04 (-0.05%)
Volume 18.66K Market Cap 646.30M
87.95 - 88.2
42 - 89.15
Start Investing

Galapagos (NASDAQ: GLPG)

Galapagos NV is a biotech firm that specializes in the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises of clinical phases, studies and discovery programs in inflammation, fibrosis and more. The company has over 1,000 employees and operates from its Mechelen, Belgium, headquarters.

The biotech stock has a market cap of $9.5 billion and an EPS of $1.56. It trades more than 25,000 shares per day. Galapagos generated $1 billion in revenue in 2019.

116.48 -0.33 (-0.28%)
Volume 17.71K Market Cap 7.60B
116.18 - 119.05
112 - 274.03
Start Investing

Amgen (NASDAQ: AMGN)

An industry-leader in biotechnology, Amgen uses cutting-edge science to develop therapies for serious illnesses. It manufactures and distributes 12 FDA approved drugs to millions of patients in over 100 countries.

With an EPS of $12.76 and a P/E ratio of 18.47, this biotech stock has a market cap of $138 billion. It reported total revenue of $23 million in 2019. Amgen offers an annual dividend yield of 2.7% per share. It has an average daily trade volume of 3.4 million shares.

Amgen has announced that the FDA has granted Fast Track designation for a drug being developed for the potential treatment of chronic heart failure. This status will allow the drug review process to be accelerated as results are expected by the 4th quarter of 2020.

216.94 -0.88 (-0.4%)
Volume 3.26M Market Cap 127.61B
213.97 - 217.26
177.05 - 264.97
Start Investing

Regeneron Pharmaceuticals (NASDAQ: REGN)

For over 30 years, Regeneron has invented life-transforming medicines for people with serious diseases. It has 7 FDA-approved drugs designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and other rare diseases.

The company stock has high liquidity with over 1 million shares traded per day. It has an EPS of $19.90 and a P/E ratio of 28.61. Regeneron has a market cap of $64 billion and reported total revenue of $67 million in 2019.

Recently, Regeneron reported promising data from clinical trials for a new drug, Libtayo. The trials showed therapeutic results in patients with advanced basal cell carcinoma. This medical condition currently has no approved treatments.

543.56 -12.23 (-2.2%)
Volume 1.17M Market Cap 55.83B
533.23 - 556
303.49 - 664.64
Start Investing

Biogen (NASDAQ: BIIB)

As pioneers in neuroscience, Biogen led innovative scientific research to treat devastating neurological diseases. It manufactures and distributes 10 FDA-approved drugs to fight multiple sclerosis, spinal muscular atrophy and Alzheimer’s disease.

Biogen has a market cap of $51 billion. It has an EPS of $32.40 and a P/E ratio of 9.69. The biotech firm reported total revenue of $14 billion in 2019. It has high liquidity with an average daily trade volume of 2 million shares.

In April 2020, Biogen announced that it will continue investing in SPINRAZA. This drug is the first FDA-approved treatment for spinal muscular atrophy.

252.07 6.59 (2.68%)
Volume 1.41M Market Cap 41.13B
243.7301 - 252.21
243.25 - 374.99
Start Investing

Benzinga's Proprietary Penny Stock Service is Finally Here

Get YOUR penny stock insights delivered straight to your inbox.

We’ll never share or sell your information. Privacy Policy.

Biggest Biotech Movers of the Day

Here’s the latest update on the biotech stocks with the biggest price movements on the stock exchange.

Stay up to date with the biggest premarket movers before trading sessions open on the stock market.

The data provided below is intended for educational purposes only, we have included the session dates for your reference.

Premarket Biotech Stocks
Symbol Last Price Change % Change Trade
MARPS 3.4 0.94 38.21% Trade
BLRX 1.995 0.515 34.79% Trade
TCDA 5.62 1.25 28.6% Trade
AIRI 1.3101 0.29 28.44% Trade
DSKE 6.5486 1.359 26.17% Trade
BBW 4.1711 0.851 25.63% Trade
ACHC 35.59 6.61 22.8% Trade
MICT 3.13 0.57 22.26% Trade
CASI 2.35 0.42 21.76% Trade
LNSR 9.81 1.65 20.22% Trade
Symbol Last Price Change % Change Trade
SNBP 2.92 -6.58 -69.27% Trade
DUOT 3.4634 -3.537 -50.53% Trade
AXGT 2.1245 -1.525 -41.8% Trade
BLCM 3.69 -2.21 -37.46% Trade
PBI 5.31 -2.11 -28.44% Trade
NTEC 2.28 -0.796 -25.88% Trade
NUZE 12.9 -4 -23.67% Trade
COLM 74.77 -21.5 -22.34% Trade
MVIS 1.73 -0.48 -21.72% Trade
TWTR 41.2501 -11.2 -21.36% Trade
Market Biotech Stocks
Symbol Last Price Change % Change Trade
NTEC 2.97 2.816 1831.07% Trade
BLRX 2.26 0.78 52.7% Trade
SDPI 0.575 0.149 35% Trade
AIRI 1.37 0.35 34.31% Trade
EQ 7.07 1.07 17.83% Trade
PLT 21.9 2.89 15.2% Trade
DZSI 11.16 1.43 14.69% Trade
MGI 5.1 0.61 13.58% Trade
DSKE 5.89 0.7 13.48% Trade
TRUP 81.5 9.44 13.1% Trade
Symbol Last Price Change % Change Trade
BLCM 3.86 -2.04 -34.58% Trade
AXGT 2.58 -1.07 -29.32% Trade
RYI 6.05 -2.03 -25.13% Trade
MVIS 1.77 -0.44 -19.91% Trade
HEXO 0.588 -0.134 -18.53% Trade
NTWK 2.0004 -0.45 -18.36% Trade
UUU 2.84 -0.51 -15.23% Trade
TWTR 44.48 -7.97 -15.2% Trade
PSHG 0.42 -0.07 -14.29% Trade
PXLW 1.97 -0.31 -13.6% Trade
After Hours Biotech Stocks
Symbol Last Price Change % Change Trade
ISIG 1.03 0.2 24.08% Trade
VHC 6.75 1.21 21.84% Trade
DNOW 4.63 0.55 13.48% Trade
VRNA 6.51 0.64 10.9% Trade
ATHE 1.37 0.13 10.48% Trade
NWGI 1.65 0.14 9.27% Trade
GTEC 1.95 0.14 7.73% Trade
GNCA 2.24 0.16 7.69% Trade
AEMD 1.44 0.1 7.46% Trade
XPL 0.45 0.03 7.14% Trade
Symbol Last Price Change % Change Trade
ORTX 3.58 -0.46 -11.39% Trade
BDR 1.17 -0.12 -9.31% Trade
PED 1.38 -0.13 -8.61% Trade
BIOX 5.555 -0.495 -8.19% Trade
NVUS 24.1 -2.08 -7.95% Trade
UUU 2.87 -0.24 -7.72% Trade
ESGC 1.78 -0.14 -7.3% Trade
NEXT 2.25 -0.17 -7.03% Trade
BLCM 3.45 -0.26 -7.01% Trade
CDEV 0.5801 -0.04 -6.4% Trade

Biotech companies are in the eye of the storm as the world slowly starts to recover from the global pandemic. Government institutions and professional traders are banking on biotech stocks to develop a vaccine to eradicate COVID-19 at the earliest. 

Tilt your stock portfolio toward biotech companies now and you could stand to make substantial profits in the near future. 

You can also find cost-effective stocks under $20 to trade daily on the stock exchange. 

Overview: Biotech Stocks

Biotech companies are a subsector of healthcare stocks that primarily focus on developing new drugs and treatments for medical conditions, diseases and viruses. The stock value and growth potential of a biotech firm depend on the type of diseases it treats. 

For instance, a biotech firm working on breast cancer treatments, which has an estimated number of 279,100 new cases in the U.S. might be more valuable than a company that is developing drugs for Ogilvie’s Syndrome, a rare disease that only affects 1%–3% of the U.S. population. 

Every new drug developed by biotech firms has to be submitted to the Food and Drug Association (FDA) for approval. Medical companies spend years developing a new drug but may fail to get it approved by the FDA. Some of these drugs will never hit the shelf of pharmaceuticals even after countless clinical trials. On the other hand, if a biotech company gets a new drug sanctioned by the FDA and the demand is high, the stock value can double or even triple overnight.  

Best Online Brokers for Biotech Stock

An online broker can help you trade biotech stocks with speed and precision. 

You can gain access to professional-level trading tools such as stock screens by opening an account on these platforms. Online brokers let you apply custom filters such as setting a price range to narrow down stocks under $10 within minutes. 

Explore these online brokers to get started today. 

Commissions
$0
Account Minimum
$0
Get started securely through Webull’s website
Commissions
$0
Account Minimum
$0
1 Minute Review

Webull, founded in 2017, is a mobile app-based brokerage that features commission-free stock and exchange-traded fund (ETF) trading. It’s regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).

Webull offers active traders technical indicators, economic calendars, ratings from research agencies, margin trading and short-selling. Webull’s trading platform is designed for intermediate and experienced traders, although beginning traders can also benefit.

Webull is widely considered one of the best Robinhood alternatives.

Best For
  • Active traders
  • Intermediate traders
  • Advanced traders
Pros
  • Commission-free trading in over 5,000 different stocks and ETFs
  • No account maintenance fees or software platform fees
  • No charges to open and maintain an account
  • Leverage of 4:1 on margin trades made the same day and leverage of 2:1 on trades held overnight
  • Intuitive trading platform with technical and fundamental analysis tools
Cons
  • Does not support trading in options, mutual funds, bonds or OTC stocks
Commissions
$0
Account Minimum
$0
Get started securely through TradeStation’s website
Commissions
$0
Account Minimum
$0
1 Minute Review

TradeStation is for advanced traders who need a comprehensive platform. The brokerage offers an impressive range of investable assets as frequent and professional traders appreciate its wide range of analysis tools. TradeStation’s app is also equally effective, offering full platform capabilities.

Best For
  • Advanced traders
  • Options and futures traders
  • Active stock traders
Pros
  • Comprehensive trading platform and professional-grade tools
  • Wide range of tradable securities
  • Fully-operational mobile app
Cons
  • Confusing pricing structure to leave new traders with a weak understanding of what they pay
  • Cluttered layout to make navigating TradeStation’s platform more difficult than it should be
Commissions
$0 $6.95 for OTC Stocks
Account Minimum
$0
Get started securely through TD Ameritrade’s website
Commissions
$0 $6.95 for OTC Stocks
Account Minimum
$0
1 Minute Review

This publicly listed discount broker, which is in existence for over four decades, is service-intensive, offering intuitive and powerful investment tools. Especially, with equity investing, a flat fee is charged, with the firm claiming that it charges no trade minimum, no data fees, and no platform fees. Though it is pricier than many other discount brokers, what tilts the scales in its favor is its well-rounded service offerings and the quality and value it offers its clients.

Best For
  • Novice investors
  • Retirement savers
  • Day traders
Pros
  • World-class trading platforms
  • Detailed research reports and Education Center
  • Assets ranging from stocks and ETFs to derivatives like futures and options
Cons
  • Thinkorswim can be overwhelming to inexperienced traders
  • Derivatives trading more costly than some competitors
  • Expensive margin rates

Features to Look for in Biotech Stock

  • Earnings per share: You can determine the profitability of a company by its earnings per share (EPS). It is calculated by dividing the net income of the company by the total number of its outstanding shares.
  • Price-earnings ratio: The price-earnings ratio (P/E ratio) is calculated by dividing the current stock price by its EPS. Based on the P/E ratio, you can assess if a stock is undervalued or overvalued. The lower the P/E ratio of the stock, the better an investment it is. Generally, penny stocks under $5 have the lowest P/E ratios. 
  • Medical innovation: Biotech firms can spend years conducting clinical trials to test a new drug. Keep a constant watch on any news regarding medical breakthroughs and FDA approvals to make the most of your trade.   

Be Patient for Better Profits

Advanced medical technology has led to longer and more fulfilling lives. An investment in biotech stocks involves longer buy-and-hold periods, but if you are patient with your trades, you can strike gold when you least expect it. 

Hire a Pro: Compare Financial Advisors In Your Area